Skip to NavigationSkip to content

Pharmafile - Sales and Marketing

Merck building
Merck and Debiopharm agree €898m deal to develop head and neck cancer treatments
German science and technology company Merck have agreed a worldwide in-licensing agreement with Debiopharm for the development and commercialisation...
Oasmia acquires rights to cancer drug candidate Cantrixil in $44m deal
Oasmia Pharmaceutical, an innovation-focused specialty pharmaceutical company, is set to acquire exclusive global development rights for Kazia...
Evotec building
Evotec and Chinook to partner on new kidney disease treatments
Evotec and Chinook Therapeutics have agreed a deal to discover and develop new therapies for patients with chronic kidney diseases (CKD).
FDA approves Johnson & Johnson's COVID-19 vaccine for emergency use
The FDA has issued emergency use authorisation for Johnson & Johnson’s one-shot COVID-19 vaccine, approving the jab for use in individuals aged...
>> More Sales and Marketing News Stories

Features

MAPs during a global pandemic

Early and managed access programmes provide opportunities for patients to get the treatments they need faster - but the COVID-19 pandemic has...

>> More Features

Appointments

Exscientia appoints Moelis & Company COO Elizabeth Crain to Board of Directors

AI-driven pharma-tech company Exscientia has appointed Elizabeth Crain to their Board of Directors.

She will use her new position to chair...

For more appointments click here

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches